Skip to content

Evaluation of RTMS on Phantom Limb Pain

Evaluation of repetitive transcranial magnetic stimulation on pain control in cancer amputee patients with Phantom Limb Pain

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180619040148N1
Enrollment
10
Registered
2018-08-02
Start date
2018-08-23
Completion date
Unknown
Last updated
2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

amputee patients with phantom limb pain. Phantom limb syndrome without pain

Interventions

Intervention group: Receiving 10 sessions' rTMS in the Primary Motor Cortex Left area using 80% MEP per person and 1000 pulses at a frequency of 5 Hz..

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Amputee Patients with phantom pain due to cancer Resistant to treatment with gabapentin or pregabalin dosage after one month Pass at least three months from the time of amputation

Exclusion criteria

Exclusion criteria: history of seizure spastic lesion in the brain Non-symmetric nerve exam with suspicion of central lesion Inability to complete the pain questionnaire vascular stent in the heart arteries or head and neck metal piece in the body

Design outcomes

Primary

MeasureTime frame
Pain score. Timepoint: Measurement of pain score before the intervention, immediately after each treatment session, one month and six months after the end of treatment. Method of measurement: McGill Pain score questioner.

Secondary

MeasureTime frame
Depression score. Timepoint: Measurement of depression score before the intervention, immediately after each treatment session, one month and six months after the end of treatment. Method of measurement: Beck Depression Inventory-II.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMasumeh Bagherzadeh Cham

Iran University of Medical Sciences

masumehbagherzadeh@gmail.com+98 21 8214 1612

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026